Recyclable nano-enzyme and application thereof
Through MnFe2O4@HNTs nanoenzyme as peroxidase, combined with colorimetric method, low detection limit and high accuracy uric acid detection is achieved, solving the problem of detection of uric acid detection height limit and nanoenzyme recovery in the prior art. The problem has wide application prospects.
Patent Information
- Application Number
- CN202411032999.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-30
- Publication Date
- 2024-12-03
AI Technical Summary
The existing peroxidase-like uric acid detection methods have high detection limits and difficult nanoenzyme recovery, which leads to unsatisfactory detection of trace uric acid and the problems of contamination and waste.
MnFe2O4@HNTs nanoenzyme is used as peroxidase-like peroxidase to detect uric acid in the peroxidation reduction reaction through its catalyst action, and the nanoenzymes can be recovered and reused by magnetic separation, and uric acid detection is performed in combination with colorimetric method.
The low detection limit (0.052μΜ) for detecting uric acid is achieved, which improves the accuracy and stability of detection, solves the problem of difficulty in recycling nanoenzymes, and significantly reduces pollution and waste, and has broad application prospects.
Smart Images

Figure CN119056464A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of biological detection technology and composite oxides, and in particular, to a recyclable nanozyme and its application; more particularly, to MnFe 2 O 4 @Application of HNTs as peroxidase-like nanozymes for detecting uric acid. Background Art
[0002] Uric acid (UA) is an important biomarker associated with a variety of metabolic disorders, including gout, hyperuricemia, and cardiovascular disease. Detection and quantification of UA in biofluids is essential for the diagnosis and monitoring of these health conditions. Currently, the main methods for determining UA in body fluids include chromatography, electrochemistry, fluorescence, and colorimetry. Colorimetry is an intuitive photometric method that is simple, fast, and low-cost, and is a common method in biochemical analysis.
[0003] Nanotechnology has transformed the field of biosensing, introducing novel nanomaterials with unique physicochemical properties. Among these nanomaterials, nanoparticles with enzyme-like activities, known as nanozymes, have attracted attention due to their stability, cost-effectiveness, and high catalytic efficiency, compared to natural enzymes. Peroxidase-like nanozymes, in particular, have been extensively studied in biosensing, environmental monitoring, and medical diagnostics.
[0004] The existing methods of using peroxidase-like enzymes to detect uric acid have high detection limits and unsatisfactory detection results for trace amounts of uric acid. In addition, the existing nanoenzymes are difficult to recover and are prone to pollution and waste. Summary of the invention
[0005] In order to solve the problems and shortcomings of the prior art, the present invention aims to provide a recyclable nanozyme and its application, specifically, providing MnFe 2 O 4 @HNTs nanozyme is used as a peroxidase-like enzyme to detect uric acid. This invention first proves that the synthesized MnFe 2 O 4 @HNTs nanozyme has peroxidase-like activity, and based on this property, a method and a kit for detecting uric acid are provided. The peroxidase nanozyme used in the present invention can be recycled and reused; the detection limit of the detection method of the present invention is 0.052μΜ, which is much lower than the detection limit of the prior art; the detection method of the present invention also has good accuracy and stability, and has broad application prospects.
[0006] To achieve the above object, the first aspect of the present invention provides a recyclable nanozyme, wherein the nanozyme comprises MnFe2O4@HNTs. 2 O4 @HNTs nanozymes can be used in peroxidase-like applications. In an embodiment of the present invention, the nanozyme can be used as a catalyst in a peroxide redox reaction. Preferably, the nanozyme can be used to detect uric acid in body fluids. In a specific embodiment of the present invention, the body fluid includes one or more of serum, plasma or urine.
[0007] The second aspect of the present invention provides a method for detecting uric acid by colorimetry, wherein the catalyst is MnFe 2 O 4 @HNTs nanozyme. Specifically, the detection steps of the method described are as follows:
[0008] 1) mixing uricase with various concentrations of uric acid standards and Britton-Robinson buffer in a centrifuge tube, and incubating at 30-40° C. for 15-20 min, preferably, at 35° C. for 15 min;
[0009] 2) Add TMB, MnFe to the reaction solution obtained in step 1) 2 O 4 @HNTs nanozyme and HAc / NaAc buffer, incubate at 45-55°C for 30-40 min, preferably at 50°C
[0010] 30min;
[0011] 3) Use a UV-visible spectrophotometer to record the absorbance of the solution at 652 nm;
[0012] 4) constructing a UA detection system according to the absorption spectrum obtained in step 3);
[0013] 5) replacing the uric acid standard in step 1) with an equal amount of the sample to be tested, repeating steps 1)-3), and calculating the uric acid concentration according to the system constructed in step 4). Preferably, the sample to be tested is a serum sample, a plasma sample or a urine sample.
[0014] In a specific embodiment of the present invention, the concentration of uricase in the above method is 12.5u·μL -1, , the dosage is 50 μL; the dosage of the uric acid standard is 50 μL; the concentration of TMB is 0.8 mM, the dosage is 200 μL; the MnFe 2 O 4 The concentration of @HNTs is 35 μg·mL-1, and the dosage is 100 μL; the concentration of the HAc / NaAc buffer is 50 mM. The pH value of the Britton-Robinson buffer is 8.5, and the final pH value of the reaction solution obtained in step 2) is 2.5.
[0015] In a specific embodiment of the present invention, the sample to be tested in step 4 is a sample diluted 50-150 times, preferably, serum or plasma is a sample diluted 100 times; urine is a sample diluted 50 times.
[0016] The third aspect of the present invention provides a kit for detecting uric acid, the kit comprising MnFe 2 O 4 @HNTs nanozymes and / or reagents for uric acid detection methods. The kit can be used to detect uric acid in body fluids, preferably, the body fluids include one or more of serum, plasma or urine.
[0017] The beneficial effects of the present invention include but are not limited to:
[0018] 1. The present invention discloses for the first time the synthesis of MnFe 2 O 4 @HNTs nanozymes have peroxidase-like activity and can be used as peroxidase-like enzymes;
[0019] 2. The MnFe2O4@HNTs nanozyme of the present invention has the advantage of being recyclable and reusable, which solves the problem of the existing nanozymes being difficult to recycle and having low utilization rate;
[0020] 3. The detection limit of the method for detecting uric acid provided by the present invention is 0.052μ Μ , which is far lower than the detection limit of existing uric acid detection methods, and has a high application prospect in the process of detecting trace uric acid;
[0021] 4. The method for detecting uric acid provided by the present invention has a recovery rate of 98.60% to
[0022] 103.70%, RSD 0.42%~1.68%. The recovery rate in spiked urine sample was 96.80%
[0023] ~100.60%, RSD is 0.7%~2.1%. Based on MnFe 2 O 4 @The detection method for uric acid in body fluids established by HNTs nanozymes has good accuracy and stability. BRIEF DESCRIPTION OF THE DRAWINGS
[0024] The drawings described herein are used to provide a further understanding of the present invention and constitute a part of the present invention. The exemplary embodiments of the present invention and their descriptions are used to explain the present invention and do not constitute an improper limitation of the present invention. In the drawings:
[0025] Figure 1 In the embodiment of the present invention, MnFe 2 O 4@HNTs peroxidase synthesis and detection mechanism of uric acid;
[0026] Figure 2 In the embodiment of the present invention, MnFe 2 O 4 @Schematic diagram of the peroxidase-like activity test results of HNTs;
[0027] Figure 3 It is a schematic diagram of the magnetic separation process and results in the recyclability test of MnFe2O4@HNTs in an embodiment of the present invention;
[0028] Figure 4 It is a schematic diagram of the results of the reuse experiment in the recyclability test of MnFe2O4@HNTs in the embodiment of the present invention;
[0029] Figure 5 It is the UV-visible absorption spectrum of the detection system in the embodiment of the present invention when adding different concentrations of uric acid (the inset is the linear interval);
[0030] Figure 6 These are photos corresponding to the detection system in the embodiment of the present invention after adding uric acid of different concentrations for reaction. DETAILED DESCRIPTION
[0031] The present invention is described in detail below with reference to examples, but the present invention is not limited to these examples. Unless otherwise specified, the raw materials and catalysts in the examples of the present invention are purchased through commercial channels.
[0032] Example 1MnFe 2 O 4 Preparation of @HNTs nanozymes
[0033] like Figure 1 As shown, MnFe 2 O 4 The preparation method of @HNTs nanozyme is:
[0034] 1) Dissolve 48.71 g of sodium oleate (160 mmol) in a solvent mixture containing 80 ml of deionized water, 100 ml of ethanol and 200 ml of n-hexane. Stir the solution at 70°C until it becomes clear;
[0035] 2) While stirring continuously, slowly add 10 ml of 2 mol / L MnCl 2 The reaction mixture was then refluxed at 70°C for 2 h;
[0036] 3) Gradually add 10ml 4mol / L FeCl 3 The organic phase was separated from the reaction mixture and washed thoroughly with deionized water to eliminate any remaining impurities.
[0037] 4) heating the organic phase in a water bath at 80° C. for 4 h to remove the organic solvent, and then drying at 110° C. overnight to obtain a mixture of metal oleates;
[0038] 5) 10 g of HNTs were uniformly stirred into the metal oleate mixture and allowed to stand for 8 h. The mixture was then heated to 450 °C at a heating rate of 10 °C / min and maintained for 4 h. After reaching room temperature, the product was ground to obtain MnFe 2 O 4 @HNTs.
[0039] Example 2MnFe 2 O 4 Verification of peroxidase activity of @HNTs
[0040] In order to evaluate the MnFe 2 O 4 @HNTs have peroxidase-like activity. 2 O 2 The ability of the catalytic enzyme to oxidize TMB with the assistance of (UA + uricase). The catalytic experiment was performed as follows:
[0041] 1) MnFe 2 O 4 @HNTs+H 2 O 2 : Prepare a mixture containing 50 μL H 2 O 2 solution (25 μM), 200 μL TMB (0.8 mM) and 1650 μL HAc–NaAc buffer (pH 2.5, 50 mM). To this solution was added 100 μL MnFe 2 O 4 @HNTs(35μg·mL -1 );
[0042] 2) MnFe 2 O 4 @HNTs+(UA+uricase): First, 50 μL uricase (12.5 U·μL -1 ) was added to a solution containing 50 μL UA (100 μM) and 150 μL Britton-Robinson buffer (pH 8.5, 0.08 M). The mixture was incubated at 37°C for 15 min. Subsequently, 100 μL MnFe 2 O 4 @HNTs(35μg·mL -1), 1450 μL HAc–NaAc buffer (pH 2.5, 50 mM), and 200 μL TMB (0.8 mM);
[0043] 3) After incubation at 50°C for 30 minutes, the absorbance of the reaction mixture was measured at 652 nm.
[0044] The results are as follows Figure 2 As shown, in MnFe 2 O 4 @HNTs, TMB and H 2 O 2 In the presence of MnFe2O, the solution quickly changes from colorless to dark blue, and a significant absorption peak at 652 nm can be clearly seen in the system, which indicates that 4 @HNTs in H 2 O 2 It has catalytic ability in the process of oxidizing TMB and has peroxidase-like activity.
[0045] Example 3: Verification of the recyclability of MnFe2O4@HNTs
[0046] In order to evaluate the recyclability of MnFe2O4@HNTs, the test was carried out under the same conditions as in Example 2. The absorbance at 652 nm was measured, and then the MnFe2O4@HNTs (such as Figure 3 As shown in the figure). After washing with deionized water, the experimental steps of Example 2 were repeated, and the whole process was repeated seven times in total.
[0047] The results are as follows Figure 4 As shown, the recycling experiments showed that MnFe2O4@HNTs retained more than 95% of their catalytic activity even after seven recycling cycles. These results highlight the excellent recyclability of the nanozymes of the present invention.
[0048] Example 4 Colorimetric measurement of uric acid
[0049] 1) Uricase (12.5u·μL-1, 50μL) and various concentrations of uric acid standards (50μL each)
[0050] and Britton-Robinson buffer (pH 8.5, 0.1 M) in a centrifuge tube. The mixture was then incubated at 35°C for 15 minutes;
[0051] 2) Add 200 μL of 0.8 mM TMB (tetramethylbenzidine), 100 μL of 35 μg mL-1 MnFe 2 O 4@HNTs and 1450 μL 50 mM HAc / NaAc buffer (pH 2.5). Then stir and continue incubation at 50°C for 30 minutes;
[0052] 3) Use a UV-visible spectrophotometer to record the absorbance of the solution at 652 nm;
[0053] 4) Construct a UA detection system through the UV-visible absorption spectra of uric acid at different concentrations.
[0054] The results are as follows Figure 5 and Figure 6 As shown in Figure 2, the absorbance of the developed UA detection system was significantly affected. The absorbance of the solution increased steadily with increasing UA levels. A robust linear relationship was observed between absorbance and UA concentration in the range of 1-20 μM, with R 2 The value was 0.996. The limit of detection (LOD) was determined to be 52 nM based on a signal-to-noise ratio (S / N) of 3. The increase in UA concentration caused the system color to gradually change to blue, which can be easily observed with the naked eye. This feature enhances the practicality of the system in practical applications.
[0055] Example 5 Analysis of uric acid in human serum
[0056] Serum samples were centrifuged at 10,000 rpm for 10 minutes. The supernatant was diluted 100 times to ensure that the uric acid content was within the measurable range. In order to calculate the spike recovery (accuracy) and relative standard deviation (RSD, n=3) (precision), the spike recovery method was used.
[0057] Steps for testing serum sample concentration:
[0058] 1) Mix 50 μL of diluted serum, 50 μL of uricase (12.5 u·μL-1) and 150 μL of BR buffer (pH=8.5) and incubate at 37°C for 15 minutes;
[0059] 2) Add 200 μL TMB (0.8 mM) and 100 μL MnFe2O4@HNTs (35 μg mL-1)
[0060] and 1450 μL HAc-NaAc buffer (50 mM, pH = 2.5) to a total volume of 2 mL. Incubate at 50°C for 30 minutes;
[0061] 3) Finally, the absorbance value was measured at 652 nm and the uric acid concentration (C1) was determined using a standard curve.
[0062] Steps to check the concentration of spiked samples:
[0063] 1) Mix 50 μL uric acid, 50 μL diluted serum, and 50 μL uricase (12.5
[0064] u·μL-1) and 150μL Britton-Robinson buffer (pH=8.5, 0.08mM)
[0065] Mix and incubate at 37°C for 15 min;
[0066] 2) Then add 200 μL TMB (0.8 mM), 100 μL MnFe2O4@HNTs (35 μg·mL-1) and 1400 μL HAc-NaAc buffer (50 mM, pH = 2.5) to a total volume of 2 mL. Incubate at 50 °C for 30 minutes;
[0067] 3) The absorbance was then measured at 652 nm, and the uric acid concentration (C2) after the addition of the uric acid standard solution was determined using the standard curve;
[0068] 4) Calculate the spike recovery rate according to the formula (Equation 1).
[0069] The formula for calculating the spike recovery rate is:
[0070] Recovery rate P = ((C2-C1) / C3) × 100%
[0071] Wherein, P is the recovery rate; C1 is the uric acid concentration in the serum sample; C2 is the uric acid concentration detected in the serum after adding the uric acid standard solution; and C3 is the concentration of the uric acid standard solution.
[0072] The test results are shown in Table 1.
[0073] Table 1 Detection results of uric acid in serum
[0074]
[0075] The accuracy of the established uric acid colorimetric detection method in serum samples was investigated by the spike recovery method. The results are shown in the table. The recovery rate in the spiked samples was 98.60% to 103.70%, and the RSD was 0.42% to 1.68%. The above results show that the detection method for uric acid in serum based on MnFe2O4@HNTs nanozyme has good accuracy and stability.
[0076] Example 6 Analysis of uric acid in human urine
[0077] The serum sample was replaced with a urine sample diluted 50 times, and the experimental steps of Example 5 were repeated. The results are shown in Table 2.
[0078] Table 2 Detection results of uric acid in urine
[0079]
[0080] The accuracy of the established uric acid colorimetric detection method in serum samples was investigated using the spike recovery method. The results are shown in the table. The recovery rate in the spiked samples was 96.8% to 100.6%, and the RSD was 0.7%.
[0081] The above results show that the detection method for uric acid in urine based on MnFe2O4@HNTs nanozymes has good accuracy and stability.
[0082] Example 7 Comparison of analytical performance of different nanozymes with peroxidase-like activity in uric acid detection The nanozymes with peroxidase-like activity recorded in the literature were searched and used to detect uric acid. The nanozymes and their corresponding literature information are shown in Table 3
[0083] Table 3 Nanozymes and their corresponding literature information
[0084]
[0085]
[0086] The verification results are shown in Table 4:
[0087] Table 4 Comparison of analytical performance of different nanozymes with peroxidase-like activity in uric acid detection
[0088]
[0089]
[0090] The detection limit of the present invention is 0.052 μM, which is significantly lower than other nanozymes, proving that the method of the present invention is more effective.
[0091] The above description is only an embodiment of the present invention. The protection scope of the present invention is not limited by these specific embodiments, but is determined by the claims of the present invention. For those skilled in the art, the present invention may have various changes and variations. Any modification, equivalent substitution, improvement, etc. made within the technical ideas and principles of the present invention should be included in the protection scope of the present invention.
Claims
1. A recyclable and reusable nanozyme, characterized in that: The nanozyme includes MnFe2O4@HNTs.
2. The nanozyme according to claim 1, characterized in that The nanozyme is used in peroxidase-like applications.
3. Use of the nanozyme as described in any one of claims 1 or 2 in detecting uric acid in body fluids.
4. The use according to claim 3, characterized in that The body fluid includes one or more of urine, plasma or serum.
5. A method for detecting uric acid using a colorimetric method, characterized in that: The catalyst is the nanozyme described in any one of claims 1 or 2.
6. The method according to claim 5, characterized in that The detection steps are as follows: 1) mixing uricase with various concentrations of uric acid standards and Britton-Robinson buffer in a centrifuge tube, and incubating at 30-40° C. for 15-20 min, preferably, at 35° C. for 15 min; 2) adding TMB, the MnFe2O4@HNTs nanozyme according to any one of claims 1 or 2, and HAc / NaAc buffer to the reaction solution obtained in step 1), and incubating at 45-55° C. for 30-40 min, preferably, at 50° C. for 30 min; 3) Use a UV-visible spectrophotometer to record the absorbance of the solution at 652 nm; 4) constructing a UA detection system according to the absorption spectrum obtained in step 3); 5) Replace the uric acid standard in step 1) with an equal amount of the sample to be tested, and repeat steps 1)-3). The uric acid concentration is calculated according to the system constructed in step 4). Preferably, the sample to be detected is one or more of a serum sample, a plasma sample or a urine sample.
7. The method according to claim 6, characterized in that The concentration of uricase is 12.5 u·μL -1, , the dosage is 50μL; the dosage of the uric acid standard is 50μL; the concentration of TMB is 0.8mM, the dosage is 200μL; the concentration of MnFe2O4@HNTs is 35 μg·mL-1, the dosage is 100 μL; the concentration of the HAc / NaAc buffer is 50 mM.
8. The method according to claim 6, characterized in that The pH value of the Britton-Robinson buffer is 8.5, and the final pH value of the reaction solution obtained in step 2) is 2.
5.
9. The method according to claim 6, characterized in that The sample to be tested in step 4 is a sample diluted 50-150 times.
10. A kit for detecting uric acid, characterized in that: The kit comprises the nanozyme described in any one of claims 1 or 2 and / or the reagents in any one of the methods described in claims 5-9.
